Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.5B | 1.6B | 1.5B | 1.6B |
Cost of revenue | 1.0B | 1.1B | 1.0B | 1.1B |
Gross profit | 426M | 502M | 495M | 520M |
Operating expense | ||||
Research & development | 42M | 47M | 45M | 50M |
Selling general and admin | 378M | 377M | 370M | 392M |
Other operating expenses | — | — | — | — |
Operating income | -4M | 35M | 70M | 68M |
Non operating interest income | ||||
Income | 2M | 4M | 3M | 4M |
Expense | 33M | 31M | 31M | 31M |
Other income expense | -32M | -12M | -1.1B | -15M |
Pretax income | -67M | -4M | -1.1B | 25M |
Tax provision | 23M | 17M | 118M | 7M |
Net income | -90M | -21M | -1.2B | 18M |
Basic EPS | -0.8 | -0.2 | -9.7 | 0.1 |
Diluted EPS | -0.8 | -0.2 | -9.7 | 0.1 |
Basic average shares | 125.2M | 124.4M | 124.3M | 124.2M |
Diluted average shares | 125.2M | 124.4M | 124.3M | 125.6M |
EBITDA | 21M | 126M | 102M | 103M |
Net income from continuing op. | -90M | -23M | -1.2B | 19M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |